Coronavirus Bharat Covacvine likely by end of 2020 , says AIIMS director

Clinical trials of the coronavirus vaccine were approved for clinical trials of the indigenous coronavirus vaccine in India.  The director of the hospital spoke to reporters on Monday during the trial in AIIMS Delhi.

                                 

Clinical trials of Corona Vaccine(Bharat Covacvine) In India likely to be available at the end of the year 2020

                     

 New Delhi:-  Clinical trials of the coronavirus vaccine were approved for clinical trials of the indigenous coronavirus vaccine in India.  

  He revealed that the trial will run in three stages at Ames.  Initially, tests will be taken on healthy volunteers between the ages of 18-55.  About 375 people will be selected for the qualifying round. 

                                      

                                       

 Within 4 or 6 weeks of volunteering, they will analyze.  "Judging by the initial importance, in the first stage we see the safety of the vaccine, which is also calculated in terms of primary importance and dose range," said Gulisia, director of AIMS.

Watch | "Wrong to say community transmission at national level': AIIMS Director Dr Randeep Guleria on #COVID19. pic.twitter.com/YqQIJZ0kYB

— NDTV (@ndtv) July 20, 2020

Video courtesy of NDTV and ANI

  He revealed that in the second phase, 750 volunteers aged 12-65 years will be tested.  "We can see how preventive it is and it follows the 3rd step, which involves the general public to evaluate its effectiveness and therapeutic benefits."

  Asked about the availability of the vaccine for public use, he said, "So, when is the vaccine available?